MHT	menopausal hormone therapy
ccMHT	continuous-combined MHT
scMHT	sequential-combined MHT
PCOS	polycystic ovary syndrome
NETA	norethisterone acetate
MPA	medroxyprogesterone acetate
PR-A	progesterone receptor alpha
PR-B	progesterone receptor beta
MAP-Ks	mitogen-activated protein kinases
ER- α	estrogen receptor-α
WHI	Women’s Health Initiative
RR	relative risk
CI	confidence interval
BMI	body mass index
HR	hazard ratio
RER	relative survival ratio
SEER	Surveillance, Epidemiology, and End Results